Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Harmony Biosciences Holdings' Other Non-Current Liabilities fell 4621.32% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 4621.32%. This contributed to the annual value of $1.9 million for FY2024, which is 768.14% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Other Non-Current Liabilities stood at $1.2 million for Q3 2025, which was down 4621.32% from $1.4 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Other Non-Current Liabilities high stood at $3.2 million for Q4 2021, and its period low was $831000.0 during Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $1.9 million (2023), whereas its average is $2.0 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Other Non-Current Liabilities soared by 27039.71% in 2022 and then crashed by 4952.22% in 2023.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Other Non-Current Liabilities stood at $3.2 million in 2021, then decreased by 21.28% to $2.5 million in 2022, then decreased by 15.67% to $2.1 million in 2023, then decreased by 7.68% to $1.9 million in 2024, then crashed by 39.09% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.4 million for Q2 2025, and $1.7 million during Q1 2025.